|Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis|
SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ...
The Lancet Global Health 5 (12), e1221-e1234, 2017
|Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis|
RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ...
The Lancet Global Health 5 (9), e888-e897, 2017
|The epidemiology of age-related macular degeneration|
R Klein, T Peto, A Bird, MR Vannewkirk
American journal of ophthalmology 137 (3), 486-495, 2004
|Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis†…|
JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ...
The Lancet Global Health 9 (2), e144-e160, 2021
|A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study): 12-month data: report 2|
M Michaelides, A Kaines, RD Hamilton, S Fraser-Bell, R Rajendram, ...
Ophthalmology 117 (6), 1078-1086. e2, 2010
|The Lancet global health Commission on global eye health: vision beyond 2020|
MJ Burton, J Ramke, AP Marques, RRA Bourne, N Congdon, I Jones, ...
The Lancet Global Health 9 (4), e489-e551, 2021
|Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study|
R Bourne, JD Steinmetz, S Flaxman, PS Briant, HR Taylor, S Resnikoff, ...
The Lancet global health 9 (2), e130-e143, 2021
|A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3|
R Rajendram, S Fraser-Bell, A Kaines, M Michaelides, RD Hamilton, ...
Archives of ophthalmology 130 (8), 972-979, 2012
|Prevalence of age-related macular degeneration in Europe: the past and the future|
JM Colijn, GHS Buitendijk, E Prokofyeva, D Alves, ML Cachulo, ...
Ophthalmology 124 (12), 1753-1763, 2017
|Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study|
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
|Macular telangiectasia type 2|
PC Issa, MC Gillies, EY Chew, AC Bird, TFC Heeren, T Peto, FG Holz, ...
Progress in retinal and eye research 34, 49-77, 2013
|Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52†…|
S Sivaprasad, AT Prevost, JC Vasconcelos, A Riddell, C Murphy, J Kelly, ...
The Lancet 389 (10085), 2193-2203, 2017
|Diabetic retinopathy: pathogenesis, clinical grading, management and future developments|
LZ Heng, O Comyn, T Peto, C Tadros, E Ng, S Sivaprasad, PG Hykin
Diabetic Medicine 30 (6), 640-650, 2013
|Screening for diabetic retinopathy: new perspectives and challenges|
S Vujosevic, SJ Aldington, P Silva, C HernŠndez, P Scanlon, T Peto, ...
The Lancet Diabetes & Endocrinology 8 (4), 337-347, 2020
|Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections|
RRA Bourne, JB Jonas, AM Bron, MV Cicinelli, A Das, SR Flaxman, ...
British Journal of Ophthalmology 102 (5), 575-585, 2018
|Redefining the overtraining syndrome as the unexplained underperformance syndrome|
R Budgett, E Newsholme, M Lehmann, C Sharp, D Jones, T Jones, T Peto, ...
British Journal of Sports Medicine 34 (1), 67-68, 2000
|Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study|
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
|Promising artificial intelligence-machine learning-deep learning algorithms in ophthalmology|
L Balyen, T Peto
The Asia-Pacific Journal of Ophthalmology 8 (3), 264-272, 2019
|Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two†…|
CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...
The Lancet 399 (10326), 741-755, 2022
|Combining algorithms for automatic detection of optic disc and macula in fundus images|
RJ Qureshi, L Kovacs, B Harangi, B Nagy, T Peto, A Hajdu
Computer Vision and Image Understanding 116 (1), 138-145, 2012